Abstract: Development of a Robust API Crystallization in a Multi-Component Solvent Mixture: Using High Throughput Automation As an Enabling Technology to Develop Comprehensive Solubility Maps (2014 Annual Meeting)

372860 Development of a Robust API Crystallization in a Multi-Component Solvent Mixture: Using High Throughput Automation As an Enabling Technology to Develop Comprehensive Solubility Maps

Thursday, November 20, 2014: 2:23 PM

301 (Hilton Atlanta)

Benjamin Cohen¹, Michelle Mahoney¹, Brenda Remy¹, Jun Qiu¹, Chris Sfouggatakis¹, Zhongping Shi¹ and Chenchi Wang², (1)Chemical Development, Bristol-Myers Squibb Co., New Brunswick, NJ, (2)Drug Product Science & Technology, Bristol-Myers Squibb Co., New Brunswick, NJ

Abstracts:

Development of a robust API crystallization in a multi-component solvent mixture.pdf (78.9KB) - Uploading Abstracts

Extended Abstract: File Not Uploaded

See more of this Session: Crystallization of Pharmaceutical and Biological Molecules
See more of this Group/Topical: Separations Division

2014 Annual Meeting

October 28 - November 2, 2012

Additional Resources

372860 Development of a Robust API Crystallization in a Multi-Component Solvent Mixture: Using High Throughput Automation As an Enabling Technology to Develop Comprehensive Solubility Maps

2014 Annual Meeting October 28 - November 2, 2012

Additional Resources

372860 Development of a Robust API Crystallization in a Multi-Component Solvent Mixture: Using High Throughput Automation As an Enabling Technology to Develop Comprehensive Solubility Maps

2014 Annual Meeting

October 28 - November 2, 2012